Search Results - "Sullivan, Harold C"

Daratumumab in multiple myeloma by Nooka, Ajay K., Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Heffner, Thomas L., Gupta, Vikas A., Sullivan, Harold C., Neish, Andrew S., Dhodapkar, Madhav V., Lonial, Sagar

“…The development of effective monoclonal antibodies for the treatment of myeloma has been a long journey of clinical and drug development. Identification of the…”
Get full text

The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases by Sullivan, Harold C, Edgar, Mark A, Cohen, Cynthia, Kovach, Charles K, HooKim, Kim, Reid, Michelle D

“…Erythroblast transformation specific related gene (ERG), a proto-oncogene member of the erythroblast transformation specific transcription factor family, is a…”
Get more information

Cytologic features of angiosarcoma: A review of 26 cases diagnosed on FNA by Geller, Rachel L., Hookim, Kim, Sullivan, Harold C., Stuart, Lauren N., Edgar, Mark A., Reid, Michelle D.

“…BACKGROUND This study describes the cytologic features of 26 angiosarcomas diagnosed on fine‐needle aspiration. METHODS Twenty‐six angiosarcomas from 20…”
Get full text

Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model by Stowell, Sean R, Arthur, C Maridith, Girard-Pierce, Kathryn R, Sullivan, Harold C, Santhanakrishnan, Manjula, Natarajan, Prabitha, Patel, Seema R, Tormey, Christopher A, Zimring, James C, Hendrickson, Jeanne E

Get full text

Hurts So Good: Uncovering the Relationship Between Blood Transfusions and Allograft Outcome by Sullivan, Harold C., Gebel, Howard M.

Get full text

Examining galectin binding specificity using glycan microarrays by Arthur, Connie M, Rodrigues, Lílian Cataldi, Baruffi, Marcelo Dias, Sullivan, Harold C, Heimburg-Molinaro, Jamie, Smith, Dave F, Cummings, Richard D, Stowell, Sean R

“…Glycan binding proteins (GBPs) possess the unique ability to regulate a wide variety of biological processes through interactions with highly modifiable cell…”
Get more information

Daratumumab (anti-CD38) induces loss of CD38 on red blood cells by Sullivan, Harold C., Gerner-Smidt, Christian, Nooka, Ajay K., Arthur, Connie M., Thompson, Louisa, Mener, Amanda, Patel, Seema R., Yee, Marianne, Fasano, Ross M., Josephson, Cassandra D., Kaufman, Richard M., Roback, John D., Lonial, Sagar, Stowell, Sean R.

Get full text

The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer by Sullivan, Harold C, Fisher, Kevin E, Hoffa, Anne L, Wang, Jason, Saxe, Debra, Siddiqui, Momin T, Cohen, Cynthia

“…Among the mutations described in non-small cell lung carcinoma is a rearrangement resulting from an inversion within chromosome 2p leading to the formation of…”
Get full text

Understanding solid-phase HLA antibody assays and the value of MFI by Sullivan, Harold C, Gebel, Howard M, Bray, Robert A

“…Abstract As the practice of medicine becomes more reliant on imaging and laboratory tests, medical decisions will be increasingly based on numbers…”
Get full text

Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report by Tambur, Anat R., Campbell, Patricia, Chong, Anita S., Feng, Sandy, Ford, Mandy L., Gebel, Howard, Gill, Ronald G., Kelsoe, Garnett, Kosmoliaptsis, Vasilis, Mannon, Roslyn B., Mengel, Michael, Reed, Elaine F., Valenzuela, Nicole M., Wiebe, Chris, Dijke, I. Esme, Sullivan, Harold C., Nickerson, Peter

“…The purpose of the STAR 2019 Working Group was to build on findings from the initial STAR report to further clarify the expectations, limitations, perceptions,…”
Get full text

Management of human leukocyte antigen-mediated platelet transfusion refractoriness: Brief synopsis and recent literature review by Panch, Sandhya R, Vassallo, Ralph R, Adams, Sharon, Borge, Dayand P, Gammon, Richard, Gandhi, Manish J, Philogene, Mary, Sullivan, Harold C, Wu, YanYun, Kopko, Patricia

Get full text

Eplet mismatch imputation studies should include immunologic risk assessment by Krummey, Scott M., Bray, Robert A., Gebel, Howard M., Sullivan, Harold C.

Get full text

Daratumumab: Beyond Multiple Myeloma by Ejaz, Kiran, Roback, John D., Stowell, Sean R., Sullivan, Harold C.

“…Daratumumab (DARA) is the biological name of an Immunoglobulin G1k human monoclonal antibody. DARA the first-in-class therapy targeting CD38 expressing- plasma…”
Get full text

The utility of second single antigen bead assay: Clearing the water or stirring up mud? by Sullivan, Harold C., Krummey, Scott M., Gebel, Howard M., Bray, Robert A.

“…Though solid-phase single antigen bead (SAB) testing has provided major advances to the HLA community and organ allocation, it has not been without…”
Get full text

How do I … implement diagnostic management teams in transfusion medicine? by Wade, Jenna, Dean, Christina L., Krummey, Scott M., Roback, John D., Sullivan, Harold C.

“…Diagnostic management teams (DMTs) were conceptualized approximately twenty years ago in response to increasing subspecialization in medicine. DMTs are a…”
Get full text

Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion by Arthur, Connie M, Patel, Seema R, Smith, Nicole H, Bennett, Ashley, Kamili, Nourine A, Mener, Amanda, Gerner-Smidt, Christian, Sullivan, Harold C, Hale, J Scott, Wieland, Andreas, Youngblood, Benjamin, Zimring, James C, Hendrickson, Jeanne E, Stowell, Sean R

“…Although RBC transfusion can result in the development of anti-RBC alloantibodies that increase the probability of life-threatening hemolytic transfusion…”
Get full text

Anti‐RhD reduces levels of detectable RhD antigen following anti‐RhD infusion by Sullivan, Harold C., Arthur, Connie M., Thompson, Louisa, Patel, Seema R., Stowell, Sean R., Hendrickson, Jeanne E., Lazarus, Alan H.

Get full text

(F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatch by Sullivan, Harold C., Dean, Christina L., Liwski, Robert S., Biswas, Shilpee, Goodman, Abigail L., Krummey, Scott, Gebel, Howard M., Bray, Robert A.

“…Flow cytometric crossmatches (FCXM) are routinely performed to support living-donor renal transplantation. While long a laboratory mainstay, a physical…”
Get full text

Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing by Dean, Christina L., Krummey, Scott M., Gebel, Howard M., Bray, Robert A., Sullivan, Harold C.

“…Previously, a distinct MHC class II Luminex-single antigen bead (SAB) pattern was described and attributed to antibodies targeting denatured antigens. In this…”
Get full text

The impact of belatacept on third‐party HLA alloantibodies in highly sensitized kidney transplant recipients by Parsons, Ronald F., Zahid, Arslan, Bumb, Shalini, Decker, Hannah, Sullivan, Harold C., Eun‐Hyung Lee, Frances, Badell, Idelberto Raul, Ford, Mandy L., Larsen, Christian P., Pearson, Thomas C., Jackson, Annette M., Chen, Dong‐Feng, Levine, Matthew, Kamoun, Malek, Bray, Robert A., Gebel, Howard M.

“…Recent evidence suggests that belatacept reduces the durability of preexisting antibodies to class I and class II human leukocyte antigens (HLAs). In this case…”
Get full text